| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |